{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:16:33Z","timestamp":1762157793827,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008984","name":"Indian Institute of Technology Kharagpur","doi-asserted-by":"publisher","award":["IIT\/SRIC\/SMST\/BHA\/2015-16\/122"],"award-info":[{"award-number":["IIT\/SRIC\/SMST\/BHA\/2015-16\/122"]}],"id":[{"id":"10.13039\/501100008984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.gene.2019.04.077","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T20:32:46Z","timestamp":1556569966000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Integrative microRNA and gene expression analysis identifies new drug repurposing candidates for fetal hemoglobin induction in \u03b2-hemoglobinopathies"],"prefix":"10.1016","volume":"706","author":[{"given":"Sankha Subhra","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant","family":"Chakravorty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2019.04.077_bb0005","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2007-01-065201","article-title":"Thalidomide induces gamma-globin gene expression through increased reactive oxygen species-mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis","volume":"110","author":"Aerbajinai","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.gene.2019.04.077_bb0010","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.gene.2019.04.077_bb0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0037-1963(01)90031-9","article-title":"Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia","volume":"38","author":"Atweh","year":"2001","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.gene.2019.04.077_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022838","article-title":"MicroRNA-96 directly inhibits gamma-globin expression in human erythropoiesis","volume":"6","author":"Azzouzi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2019.04.077_bb0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2141.2007.06673.x","article-title":"Expression of the gamma-globin gene is sustained by the cAMP-dependent pathway in beta-thalassaemia","volume":"138","author":"Bailey","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.gene.2019.04.077_bb0030","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ng1590","article-title":"Identification of hundreds of conserved and nonconserved human microRNAs","volume":"37","author":"Bentwich","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2019.04.077_bb0035","doi-asserted-by":"crossref","first-page":"D149","DOI":"10.1093\/nar\/gkm995","article-title":"The microRNA.org resource: targets and expression","volume":"36","author":"Betel","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2019.04.077_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40291-016-0187-2","article-title":"Structural and functional insights on an uncharacterized Agamma-globin-gene polymorphism present in four beta0-thalassemia families with high fetal hemoglobin levels","volume":"20","author":"Bianchi","year":"2016","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.gene.2019.04.077_bb0045","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/leu.2012.44","article-title":"The miR-17 approximately 92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes","volume":"26","author":"Bomben","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.gene.2019.04.077_bb0050","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng.630","article-title":"Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin","volume":"42","author":"Borg","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2019.04.077_bb0055","doi-asserted-by":"crossref","first-page":"12617","DOI":"10.1073\/pnas.1006774107","article-title":"Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease","volume":"107","author":"Bradner","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2019.04.077_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2017.29","article-title":"A standard database for drug repositioning","volume":"4","author":"Brown","year":"2017","journal-title":"Sci Data"},{"key":"10.1016\/j.gene.2019.04.077_bb0065","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ajpath.2015.01.025","article-title":"The PTEN-AKT-mTOR\/RICTOR pathway in nasal natural killer cell lymphoma is activated by miR-494-3p via PTEN but inhibited by miR-142-3p via RICTOR","volume":"185","author":"Chen","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.gene.2019.04.077_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818785512","article-title":"Photodynamic therapy mediated by aloe-emodin inhibited angiogenesis and cell metastasis through activating MAPK signaling pathway on HUVECs","volume":"17","author":"Chen","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.gene.2019.04.077_bb0075","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.nbt.2018.05.957","article-title":"MicroRNA\u2013mRNA interaction network indicates a major role of MAPK pathway in fetal hemoglobin reactivation in beta-thalassemia","volume":"44","author":"Das","year":"2018","journal-title":"New Biotechnol."},{"key":"10.1016\/j.gene.2019.04.077_bb0080","article-title":"Identification of deleterious SNPs and their effects on BCL11A, the master regulator of fetal hemoglobin expression","author":"Das","year":"2019","journal-title":"Genomics"},{"key":"10.1016\/j.gene.2019.04.077_bb0085","series-title":"Database 2018","first-page":"bay023","article-title":"miRwayDB: a database for experimentally validated microRNA-pathway associations in pathophysiological conditions","author":"Das","year":"2018"},{"key":"10.1016\/j.gene.2019.04.077_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ygeno.2018.01.002","article-title":"Diseases and their clinical heterogeneity - are we ignoring the SNiPers and micRomaNAgers? An illustration using Beta-thalassemia clinical spectrum and fetal hemoglobin levels","volume":"111","author":"Das","year":"2019","journal-title":"Genomics"},{"key":"10.1016\/j.gene.2019.04.077_bb0095","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/13543784.16.7.1111","article-title":"Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma","volume":"16","author":"Duvic","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.gene.2019.04.077_bb0100","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nmeth.3485","article-title":"miRWalk2.0: a comprehensive atlas of microRNA-target interactions","volume":"12","author":"Dweep","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.gene.2019.04.077_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-4939-1062-5_25","article-title":"miRWalk database for miRNA-target interactions","volume":"1182","author":"Dweep","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.gene.2019.04.077_bb0110","first-page":"47","article-title":"Evaluation of novel fetal hemoglobin inducer drugs in treatment of beta-hemoglobinopathy disorders","volume":"7","author":"Fard","year":"2013","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"10.1016\/j.gene.2019.04.077_bb0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/asheducation-2006.1.58","article-title":"Induction of fetal hemoglobin in the treatment of sickle cell disease","author":"Fathallah","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.gene.2019.04.077_bb0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/pr.2013.227","article-title":"Emerging science of hydroxyurea therapy for pediatric sickle cell disease","volume":"75","author":"Green","year":"2014","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.gene.2019.04.077_bb0125","doi-asserted-by":"crossref","first-page":"D140","DOI":"10.1093\/nar\/gkj112","article-title":"miRBase: microRNA sequences, targets and gene nomenclature","volume":"34","author":"Griffiths-Jones","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2019.04.077_bb0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic roles of curcumin: lessons learned from clinical trials","volume":"15","author":"Gupta","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.gene.2019.04.077_bb0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.gene.2019.04.077_bb0140","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1182\/blood.V116.21.1622.1622","article-title":"Hydroxyurea induces fetal hemoglobin expression by activating cAMP signaling pathways in a cAMP- and cGMP-dependent manner; new hypothesis to account for a role of non-erythroid cells in fetal hemoglobin induction","volume":"116","author":"Ikuta","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.gene.2019.04.077_bb0145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jcp.22093","article-title":"Curcumin stimulates glucose uptake through AMPK-p38 MAPK pathways in L6 myotube cells","volume":"223","author":"Kim","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.gene.2019.04.077_bb0150","first-page":"532","article-title":"Hemoglobinopathies: clinical manifestations, diagnosis, and treatment","volume":"108","author":"Kohne","year":"2011","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.gene.2019.04.077_bb0155","first-page":"3347","article-title":"Activation of p38 mitogen-activated protein kinase is necessary for gemcitabine-induced cytotoxicity in human pancreatic cancer cells","volume":"25","author":"Koizumi","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.gene.2019.04.077_bb0160","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.3892\/etm.2016.3793","article-title":"Emodin inhibits migration and invasion of MHCC-97H human hepatocellular carcinoma cells","volume":"12","author":"Lin","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.gene.2019.04.077_bb0165","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jgr.2016.06.005","article-title":"The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity","volume":"41","author":"Lin","year":"2017","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.gene.2019.04.077_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/bioinformatics\/bts698","article-title":"SM2miR: a database of the experimentally validated small molecules' effects on microRNA expression","volume":"29","author":"Liu","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.gene.2019.04.077_bb0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13073-014-0094-2","article-title":"Deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis","volume":"6","author":"Liu","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.gene.2019.04.077_bb0180","article-title":"DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2019.04.077_bb0185","doi-asserted-by":"crossref","first-page":"41638","DOI":"10.18632\/oncotarget.5873","article-title":"MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt\/beta-catenin pathway","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2019.04.077_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060436","article-title":"MicroRNA-486-3p regulates gamma-globin expression in human erythroid cells by directly modulating BCL11A","volume":"8","author":"Lulli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2019.04.077_bb0195","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.exphem.2008.06.014","article-title":"A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger","volume":"36","author":"Mabaera","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.gene.2019.04.077_bb0200","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cell.2006.07.031","article-title":"A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes","volume":"126","author":"Miranda","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.gene.2019.04.077_bb0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s13238-012-2053-2","article-title":"Curcumin induces differentiation of embryonic stem cells through possible modulation of nitric oxide-cyclic GMP pathway","volume":"3","author":"Mujoo","year":"2012","journal-title":"Protein Cell"},{"key":"10.1016\/j.gene.2019.04.077_bb0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.2011.08916.x","article-title":"Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin","volume":"156","author":"Ngo","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.gene.2019.04.077_bb0215","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/blood-2015-03-635391","article-title":"Phase 1\/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea","volume":"125","author":"Okam","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.gene.2019.04.077_bb0220","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2011-03-341909","article-title":"A pilot study of subcutaneous decitabine in beta-thalassemia intermedia","volume":"118","author":"Olivieri","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.gene.2019.04.077_bb0225","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1177\/1535370215596859","article-title":"Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: strategies to treat sickle cell disease","volume":"240","author":"Pace","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.gene.2019.04.077_bb0230","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcmd.2011.03.003","article-title":"Regulation of gamma-globin gene expression involves signaling through the p38 MAPK\/CREB1 pathway","volume":"47","author":"Ramakrishnan","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.gene.2019.04.077_bb0235","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ajh.20575","article-title":"Novel valproic acid derivatives with hemoglobin F inducing activity","volume":"81","author":"Ronndahl","year":"2006","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.gene.2019.04.077_bb0240","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1073\/pnas.1018384108","article-title":"MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13","volume":"108","author":"Sankaran","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2019.04.077_bb0245","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/bib\/bbr021","article-title":"Drug repositioning for orphan diseases","volume":"12","author":"Sardana","year":"2011","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.gene.2019.04.077_bb0250","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.gene.2019.04.077_bb0255","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1007\/s11095-011-0608-1","article-title":"Subcellular fate and off-target effects of siRNA, shRNA, and miRNA","volume":"28","author":"Singh","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.gene.2019.04.077_bb0260","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.V89.3.1078","article-title":"Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea","volume":"89","author":"Steinberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.gene.2019.04.077_bb0265","first-page":"2017","article-title":"miRnalyze: an interactive database linking tool to unlock intuitive microRNA regulation of cell signaling pathways","author":"Subhra Das","year":"2017","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.gene.2019.04.077_bb0270","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00277-010-0980-7","article-title":"Expression of microRNA-451 in normal and thalassemic erythropoiesis","volume":"89","author":"Svasti","year":"2010","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.gene.2019.04.077_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","article-title":"CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks","volume":"127","author":"Tang","year":"2015","journal-title":"Biosystems"},{"key":"10.1016\/j.gene.2019.04.077_bb0280","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1742-7843.2006.pto_348.x","article-title":"Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide","volume":"98","author":"Wang","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.gene.2019.04.077_bb0285","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1743-6109.2009.01482.x","article-title":"Ginsenoside Rg1 improves male copulatory behavior via nitric oxide\/cyclic guanosine monophosphate pathway","volume":"7","author":"Wang","year":"2010","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.gene.2019.04.077_bb0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.10161","article-title":"Induction of fetal hemoglobin synthesis by valproate: modulation of MAP kinase pathways","volume":"71","author":"Witt","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.gene.2019.04.077_bb0295","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3324\/haematol.2009.013870","article-title":"Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma","volume":"95","author":"Wozniak","year":"2010","journal-title":"Haematologica"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919304354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919304354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:24:01Z","timestamp":1759854241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111919304354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":59,"alternative-id":["S0378111919304354"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2019.04.077","relation":{},"ISSN":["0378-1119"],"issn-type":[{"type":"print","value":"0378-1119"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative microRNA and gene expression analysis identifies new drug repurposing candidates for fetal hemoglobin induction in \u03b2-hemoglobinopathies","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2019.04.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}